Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2019-12-13 Sale | 2019-12-17 8:00 pm | Sarepta Therapeutics Inc. | SRPT | Mahatme Sandesh EVP, CFO & CBO | 125,000 | $125.5 | $15,687,500 | 98,060 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-05-30 Option Award | 2024-05-31 4:15 pm | N/A 2034-05-30 | CRISPR Therapeutics AG | CRSP | Mahatme Sandesh Director | 13,000 | $0 | 13,000 (Direct) | View |
Ownership | 2024-05-30 4:27 pm | N/A 2033-10-16 | CRISPR Therapeutics AG | CRSP | Mahatme Sandesh Director | 0 | $0 | 26,000 (Direct) | View |
2022-06-07 Option Award | 2022-06-09 9:18 pm | N/A 2032-06-06 | Aeglea BioTherapeutics Inc. | AGLE | Mahatme Sandesh Director | 43,000 | $0 | 43,000 (Direct) | View |
2021-06-08 Option Award | 2021-06-09 5:26 pm | N/A 2031-06-07 | Aeglea BioTherapeutics Inc. | AGLE | Mahatme Sandesh Director | 40,000 | $0 | 40,000 (Direct) | View |
2020-07-08 Exercise | 2020-07-09 8:00 pm | 2018-03-10 2027-03-10 | Sarepta Therapeutics Inc. | SRPT | Mahatme Sandesh EVP, CFO & CBO | 1,203 | $32.63 | 32,272 (Direct) | View |
2020-07-08 Exercise | 2020-07-09 8:00 pm | 2017-02-28 2026-02-28 | Sarepta Therapeutics Inc. | SRPT | Mahatme Sandesh EVP, CFO & CBO | 2,603 | $13.71 | 32,272 (Direct) | View |
2020-05-11 Gift | 2020-07-09 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Mahatme Sandesh EVP, CFO & CBO | 20,425 | $0 | 32,272 (Direct) | View |
2020-06-10 Option Award | 2020-06-12 4:17 pm | N/A 2030-06-09 | Flexion Therapeutics Inc | FLXN | Mahatme Sandesh Director | 11,500 | $0 | 11,500 (Direct) | View |
2020-06-08 Option Award | 2020-06-10 4:28 pm | N/A 2030-06-07 | Aeglea BioTherapeutics Inc. | AGLE | Mahatme Sandesh Director | 28,100 | $0 | 28,100 (Direct) | View |
2020-02-28 Option Award | 2020-02-28 8:00 pm | N/A 2030-02-28 | Sarepta Therapeutics Inc. | SRPT | Mahatme Sandesh EVP, CFO & CBO | 44,200 | $0 | 86,391 (Direct) | View |
2019-12-13 Exercise | 2019-12-17 8:00 pm | 2017-02-28 2026-02-28 | Sarepta Therapeutics Inc. | SRPT | Mahatme Sandesh EVP, CFO & CBO | 125,000 | $0 | 98,060 (Direct) | View |
2019-12-13 Exercise | 2019-12-17 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Mahatme Sandesh EVP, CFO & CBO | 14,723 | $34.92 | 98,060 (Direct) | View |
2019-12-13 Exercise | 2019-12-17 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Mahatme Sandesh EVP, CFO & CBO | 10,466 | $23.85 | 98,060 (Direct) | View |
2019-12-13 Exercise | 2019-12-17 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Mahatme Sandesh EVP, CFO & CBO | 69,479 | $29.03 | 98,060 (Direct) | View |
2019-12-13 Exercise | 2019-12-17 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Mahatme Sandesh EVP, CFO & CBO | 21,875 | $32.63 | 98,060 (Direct) | View |
2019-12-13 Exercise | 2019-12-17 8:00 pm | N/A N/A | Sarepta Therapeutics Inc. | SRPT | Mahatme Sandesh EVP, CFO & CBO | 8,457 | $13.71 | 98,060 (Direct) | View |